Kanes Stephen 4
4 · Centessa Pharmaceuticals plc · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Share Option (right to buy)
[F1][F2]2025-02-03+500,000→ 500,000 totalExercise: $16.90Exp: 2035-02-03→ Ordinary Shares (500,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on February 3, 2026 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Signature
/s/ Gregory Weinhoff, attorney-in-fact|2025-02-04